Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD of Mural Oncology plc from Q1 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Mural Oncology plc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and change rate from Q1 2023 to Q3 2025.
  • Mural Oncology plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Sep 2025 was -$3.71M, a 88.3% increase year-over-year.
  • Mural Oncology plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending 30 Sep 2025 was -$119M, a 22.5% increase year-over-year.
  • Mural Oncology plc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2024 was -$128M, a 38.1% increase from 2023.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Change (%)

Mural Oncology plc Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$119M -$3.71M +$28M +88.3% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$147M -$48M -$16.4M -52.1% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 -$131M -$33.2M -$2.17M -6.99% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$128M -$34.3M +$25.2M +42.4% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$154M -$31.7M +$19.6M +38.3% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$173M -$31.5M +$18.6M +37.1% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025
Q1 2024 -$192M -$31M +$15.5M +33.3% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$207M -$59.5M 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$51.3M 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$50.2M 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$46.5M 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024

Mural Oncology plc Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$128M +$79M +38.1% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$207M 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.